New Century Financial Group LLC Acquires 620 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

New Century Financial Group LLC boosted its stake in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 15.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,575 shares of the company’s stock after buying an additional 620 shares during the quarter. New Century Financial Group LLC’s holdings in Henry Schein were worth $346,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HSIC. McGlone Suttner Wealth Management Inc. bought a new position in shares of Henry Schein during the 4th quarter worth approximately $39,000. Neo Ivy Capital Management purchased a new position in Henry Schein in the third quarter worth $46,000. Mather Group LLC. bought a new position in Henry Schein in the 1st quarter valued at $97,000. Benjamin F. Edwards & Company Inc. grew its stake in Henry Schein by 37.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock valued at $114,000 after purchasing an additional 416 shares during the period. Finally, GAMMA Investing LLC bought a new position in Henry Schein in the 4th quarter valued at $115,000. 96.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HSIC has been the subject of a number of recent analyst reports. Barrington Research upped their price objective on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, May 8th. Piper Sandler restated an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research note on Friday, June 21st. Finally, UBS Group reduced their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Hold” and a consensus price target of $81.73.

Get Our Latest Report on HSIC

Henry Schein Stock Down 1.2 %

HSIC stock opened at $64.79 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. The company has a market capitalization of $8.30 billion, a price-to-earnings ratio of 21.89, a PEG ratio of 1.60 and a beta of 0.87. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The stock has a fifty day moving average of $69.30 and a 200-day moving average of $72.64.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.21 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.